These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Ofloxacin: antibacterial activity, induction of resistance and killing curves. Husson MO; Izard D; Bryskier A; Leclerc H Chemioterapia; 1985 Aug; 4(4):278-83. PubMed ID: 3863716 [TBL] [Abstract][Full Text] [Related]
24. [In vitro activity and resistance of 4-quinolones]. Bauernfeind A Infection; 1986; 14 Suppl 3():S186-7. PubMed ID: 3531027 [No Abstract] [Full Text] [Related]
25. [In vitro studies of compounds of antibacterial substances. 2. Bacteriostatic effect of some compounds of 8-hydroxyquinoline derivatives]. Weuffen W; Hilpert L Z Gesamte Hyg; 1967 Sep; 13(9):672-6. PubMed ID: 5618564 [No Abstract] [Full Text] [Related]
26. In vitro activity of four new quinolones in Mueller-Hinton broth and peritoneal dialysis fluid. Weissauer-Condon C; Engels I; Daschner FD Eur J Clin Microbiol; 1987 Jun; 6(3):324-6. PubMed ID: 3622502 [No Abstract] [Full Text] [Related]
27. Recent advances in pharmaceutical chemistry. The 4-quinolone antibiotics. Jack DB J Clin Hosp Pharm; 1986 Apr; 11(2):75-93. PubMed ID: 3519688 [No Abstract] [Full Text] [Related]
28. An investigation of the hydrophobicity of the quinolones. Ashby J; Piddock LJ; Wise R J Antimicrob Chemother; 1985 Dec; 16(6):805-8. PubMed ID: 3005220 [No Abstract] [Full Text] [Related]
30. Synthesis and characterization of norfloxacin-transition metal complexes (group 11, IB): spectroscopic, thermal, kinetic measurements and biological activity. Refat MS Spectrochim Acta A Mol Biomol Spectrosc; 2007 Dec; 68(5):1393-405. PubMed ID: 17467332 [TBL] [Abstract][Full Text] [Related]
31. [Quinolones--increased possibilities of antibacterial therapy]. Novácek L Cas Lek Cesk; 1988 Feb; 127(6):184-7. PubMed ID: 3359477 [No Abstract] [Full Text] [Related]
32. The quinolones and dermatologic practice. Parish LC; Witkowski JA Int J Dermatol; 1986; 25(6):351-6. PubMed ID: 3531041 [No Abstract] [Full Text] [Related]
33. Studies on prodrugs. IV. Preparation and characterization of N-(5-substituted 2-oxo-1,3-dioxol-4-yl)methyl norfloxacin. Sakamoto F; Ikeda S; Kondo H; Tsukamoto G Chem Pharm Bull (Tokyo); 1985 Nov; 33(11):4870-7. PubMed ID: 3830420 [No Abstract] [Full Text] [Related]
34. Antibacterial activities of some bisisoquinolinium salts. COLLIER HO; POTTER MD; TAYLOR EP Br J Pharmacol Chemother; 1953 Mar; 8(1):34-7. PubMed ID: 13066690 [No Abstract] [Full Text] [Related]
35. Studies in detoxication. 57. The structure of the glucuronides from 2- and 4-quinolones and the orientation of biological hydroxylation in quinolones. SMITH JN; WILLIAMS RT Biochem J; 1954 Feb; 56(2):325-9. PubMed ID: 13140195 [No Abstract] [Full Text] [Related]
36. Some pharmacological and microbiological properties of chlorhydroxyquinoline and related compounds. HESELTINE WW; FREEMAN FM J Pharm Pharmacol; 1959 Mar; 11(3):169-74. PubMed ID: 13631630 [No Abstract] [Full Text] [Related]
38. T cell-mediated hypersensitivity to quinolones: mechanisms and cross-reactivity. Schmid DA; Depta JP; Pichler WJ Clin Exp Allergy; 2006 Jan; 36(1):59-69. PubMed ID: 16393267 [TBL] [Abstract][Full Text] [Related]
39. Pefloxacin--a laboratory and clinical evaluation of a new quinolone. Based on papers presented at the 14th International Congress of Chemotherapy. Kyoto, Japan, June 1985. J Antimicrob Chemother; 1986 Apr; 17 Suppl B():1-118. PubMed ID: 3458695 [No Abstract] [Full Text] [Related]
40. Bacterial resistance to norfloxacin and other newer quinolones: pattern and prospects. Nalin DR Eur J Cancer Clin Oncol; 1988; 24 Suppl 1():S55-61. PubMed ID: 3280327 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]